Rapport technique final du Projet de recherche-action-Formation.
Le projet «Développement d’une plateforme eS@nté Communautaire au Sénégal, avec application dans la santé maternelle et infantile pour l’atteinte des OMD Santé » est une initiative de la FMPOS, de l’Institut de Santé D...éveloppement (ISED), de l’École Supérieure Polytechnique (ESP) de l’Université Cheikh Anta Diop de Dakar, en collaboration avec le Service National de l’Information Sanitaire (SNIS) et la Division de la Santé et de la Reproduction (DSR) du Ministère de la Santé du Sénégal, et le Projet des Villages du Millénaire à Louga.
more
Women have less access to the development services and support – such as adequate healthcare, education and
modern technology – that make people more resilient to climate change and other shocks and stressors.2
Women’s unequal access to resources, their disproportionate responsibility for ca...re of dependents (typically unpaid),
and the insecurity and precariousness of their paid labour all contribute to the feminisation of poverty and women’s
heightened vulnerability to climate hazards. Climate change is a multiplier of existing vulnerabilities and threatens to
reverse hard-earned development gains for all people, and particularly for women.
more
Country Strategic Plan Evaluations (CSPEs) encompass the WFP strategy and entirety of WFP activities during a specific period. Their purpose is twofold: 1) to provide evaluation evidence and learning on WFP's performance for country-level strategic decisions, specifically for developing the next Cou...ntry Strategic Plan (CSP) and 2) to provide accountability for results to WFP stakeholders. These evaluations are mandatory for all CSPs and are carried out in line with the WFP Policy on Country Strategic Plans and the WFP Evaluation Policy.
more
Each year since 2007, G-FINDER has provided policy-makers, donors, researchers and industry with a comprehensive analysis of global investment into research and development of new products to
prevent, diagnose, control or cure neglected diseases in low- and middle-income countries, making it the go...ld standard in tracking and reporting global funding for neglected disease R&D. This year’s report, the sixteenth overall, focuses on investments made in participants’ 2022 financial year (‘FY2022’) and, for the first time, adds comprehensive coverage of the product pipeline in each disease area.
more